Company Filing History:
Years Active: 1998
Title: Johan Dixelius: Innovator in Protein Production
Introduction
Johan Dixelius is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant human proteins. His innovative approach has the potential to impact the treatment of hemophilia A, a serious blood disorder.
Latest Patents
Dixelius holds a patent for a process aimed at enhancing the production of recombinant human proteins. The patent, titled "Process for producing a protein," outlines a method for reducing the detrimental influence of certain proteases on protein production in cell cultures. This process involves adding inhibitors of metal-dependent proteases or chymotrypsins to the cell culture medium. The resulting recombinant factor VIII produced through this method is beneficial for creating medicaments for patients suffering from hemophilia A.
Career Highlights
Johan Dixelius has worked with Pharmacia & Upjohn AB, where he has applied his expertise in biotechnology to advance the production of therapeutic proteins. His work has been instrumental in developing methods that improve the efficiency and effectiveness of protein production in laboratory settings.
Collaborations
Dixelius has collaborated with notable colleagues, including Lars Adamson and Erik Walum. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.
Conclusion
Johan Dixelius is a pioneering inventor whose work in protein production has the potential to transform treatments for hemophilia A. His innovative processes and collaborations highlight the importance of research and development in biotechnology.